wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33500786-32E88615-61C2-4ECE-A6C8-AA036B815592
Q33500786-32E88615-61C2-4ECE-A6C8-AA036B815592
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33500786-32E88615-61C2-4ECE-A6C8-AA036B815592
Current data of targeted therapies for the treatment of triple-negative advanced breast cancer: empiricism or evidence-based?
P2860
Q33500786-32E88615-61C2-4ECE-A6C8-AA036B815592
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33500786-32E88615-61C2-4ECE-A6C8-AA036B815592
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7a0d3b09ffd9caf1b507488894652207bb21439d
P2860
Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitro.